Pfizer (PFE) Tops Q1 EPS by 25c; reaffirms guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $27.91 -0.07%
EPS Growth %: -12.6%
Financial Fact:
Provision for taxes on income: 284M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -12.6%
Financial Fact:
Provision for taxes on income: 284M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $1.23, $0.25 better than the analyst estimate of $0.98. Revenue for the quarter came in at $18.3 billion versus the consensus estimate of $16.64 billion.
GUIDANCE:
Pfizer sees FY2023 EPS of $3.25-$3.45, versus the consensus of $3.36. Pfizer sees FY2023 revenue of $67-71 billion, versus the consensus of $68.67 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Scotiabank Reiterates Sector Outperform Rating on Ero Copper Corp. (ERO:CN) (ERO)
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
